Understanding Blood Flow: The other Side of an Acute Arterial Occlusion

Abstract

Get full access to this article

View all access options for this article.

References

Liebeskind

: Collaterals in acute stroke: Beyond the clot. Neuroimaging Clin N Am 2005; 15: 553–73.

Fisher

Albers

Donnan

. For the stroke therapy academic industry roundtable IV. Enhancing the development and approval of acute stroke therapies: Stroke therapy academic industry roundtable. Stroke 2005; 36: 1808–13.

http://www.astrazeneca.com/pressrelease/5279.aspx, Accessed October 28, 2006.

Lees

Zivin

Ashwood

Davalos

Davis

Diener

. NXY-059 for acute ischemic stroke. N Engl J Med 2006; 354: 588–600.

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–8.

Albers

Thijs

Wechsler

. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508–17.

del Zoppo

Poeck

Pessin

. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78–86.

Liebeskind

: Neuroprotection from the collateral perspective. IDrugs 2005; 8: 222–8.

Liebeskind

: Collateral therapeutics for cerebral ischemia. Expert Rev Neurother 2004; 4: 255–65.